Barclays maintains an 'Overweight' on Health Management Associates (NYSE: HMA), lowers price target to $10 from $11 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE